The Indian Council of Medical Research (ICMR) has selected 12 institutes for the Phase-I and Phase-II clinical trials of the first indigenously developed COVID-19 vaccine BBV152 (commonly known as COVAXIN).
COVAXIN is developed by Hyderabad based vaccine & bio-therapeutics manufacturer-Bharat Biotech.
COVAXIN is the first indigenously developed COVID-19 vaccine to be approved for Human Clinical Trials.
